Delivery Order SPE2DB22D1017-SPE2DB25FYRBY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Venclexta 100 mg tablets (120 count) at a ceiling value of $9,728.17. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is set for ultimate completion by May 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with an ultimate completion date of October 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Venclexta 100 mg tablets (120 count) with a ceiling value of $9,728.17. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures. The order is scheduled for completion by October 9, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on August 21, 2025, with completion targeted for September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. Venclexta is a specialized oncology medication used in the treatment of chronic lymphocytic leukemia and other...
- The Defense Logistics Agency awarded a $19,456.34 delivery order to AmerisourceBergen Drug Corp for 120 tablets of Venclexta 100 mg on July 22, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. Venclexta is a prescription medication used in the treatment of certain blood cancers, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $9,728.17 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count unit of use packaging). This is a firm fixed price delivery order with no set-aside designation, issued on July 14, 2025, with an ultimate completion date of August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Venclexta is a prescription oncology medication used in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with a completion date of October 6, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a continuation of the company's pharmaceutical supply services to the federal government. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 6, 2025, and represents a delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (28-count units) valued at $2,289.70. The contract, awarded on August 6, 2025, with an ultimate completion date of August 27, 2025, represents a firm fixed-price, non-competitive set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYRBYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with completion targeted for October 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. Venclexta is a targeted cancer therapy used primarily in the treatment of chronic lymphocytic leukemia and other hematologic malignancies, reflecting the Defense Logistics Agency's ongoing pharmaceutical supply requirements for military healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, holds a $999,999,999.00 IDC with DLA Troop Support Medical (designated SPE2DX) running through December 2026 that serves as the overarching vehicle for this delivery order. The prime contract enables the company to supply a comprehensive range of pharmaceutical products and medical commodities to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, and vaccines. This award demonstrates AmerisourceBergen's ongoing role in fulfilling federal pharmaceutical procurement needs across military and veteran healthcare systems, positioning the company as a key supplier within the Department of Defense's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 9/17/25 |